Prihlásiť sa Zaregistrujte sa zadarmo

SMA 200 spoločnosti Genocea Biosciences Inc

Aká je hodnota metriky SMA 200 spoločnosti Genocea Biosciences Inc?

Hodnota metriky SMA 200 spoločnosti Genocea Biosciences Inc je $0 -Inf%

Aká je definícia metriky SMA 200?



SMA 200 (Simple Moving Average 200) je priemerná cena akcie za posledných 200 dní vypočítaná ako nevážený priemer z predchádzajúcich 200 záverečných cien.

Simple moving average of 200 days for a stock is an unweighted moving average over the past 200 days. Moving averages will always exhibit a lag and the longer the period used for averaging the greater the lag will be. Because of the large amounts of data considered when calculating a long-term moving average, it takes a considerable amount of movement in the market to cause the moving average to change its course.

Using a moving average to confirm a trend in price is one of the most basic, yet effecting ways of using the indicator. Moving averages take into account what has already happened and a whole range of past events, which makes them such a good technical analysis tool for trend confirmations. Generally, a long-term moving average that is clearly on the upswing is a confirmation of a bullish trend. Conversely, a long-term moving average that is clearly on the downswing is a confirmation of a bearish trend.

SMA 200 spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Genocea Biosciences Inc

Čomu sa venuje spoločnosť Genocea Biosciences Inc?

Genocea's mission is to conquer cancer by developing personalized cancer immunotherapies in multiple tumor types. Our unique ATLAS™ platform comprehensively profiles each patient's T cell responses to potential targets, or antigens, on the tumor. ATLAS enables us to optimize the neoantigens for inclusion in our immunotherapies and exclude inhibitory antigens, Inhibigens™, that can exert an immunosuppressive effect. We are advancing two ATLAS-enabled programs: GEN-009, our neoantigen vaccine and GEN-011, our neoantigen-specific cell therapy using T cells derived from peripheral blood.

Firmy s metrikou sma 200 podobnou spoločnosti Genocea Biosciences Inc